1-6 of 6
Sylvain Choquet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy

Vincent Camus, Roch Houot, Gabriel Brisou, Benoit Tessoulin, Sébastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Franck Morschhauser, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérome Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5371–5381.
https://doi.org/10.1182/bloodadvances.2024013726
Published: 2024
Includes: Supplemental data
Journal Articles

Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)

Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Franck Morschhauser, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques-Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stéphanie Guidez, Michaël Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Mathilde Guillet, Roch Houot
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1573–1585.
https://doi.org/10.1182/bloodadvances.2023011727
Published: 2024
Includes: Supplemental data
Journal Articles

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study

Clinical Trials & Observations
Paul Lesueur, Gandhi Damaj, Khê Hoang-Xuan, Virginie Roland, Anna Schmitt, Olivier Chinot, Michel Fabbro, Philippe Agapé, Cécile Moluçon-Chabrot, Safia Chebrek, Agusti Alentorn, Loic Feuvret, Daniel Delgadillo, Dinu Stefan, Sylvain Choquet, Lucia Nichelli, Karima Mokhtari, Bertrand Mathon, Sylvain Dureau, Carole Soussain, Caroline Houillier
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4807–4815.
https://doi.org/10.1182/bloodadvances.2022007011
Published: 2022
Includes: Supplemental data
Journal Articles

Prevalence of IGLV3-21 R110 among familial CLL: a retrospective study of 45 cases

Marine Armand, Patricia Verrier, Floriane Theves, Clotilde Bravetti, Magali Le Garff-Tavernier, Sylvain Choquet, Frédéric Davi
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3632–3635.
https://doi.org/10.1182/bloodadvances.2021006658
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Clinical Trials & Observations
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3862–3872.
https://doi.org/10.1182/bloodadvances.2021004778
Published: 2021
Includes: Supplemental data
Journal Articles

Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire

Nabila Belhouachi, Aliki Xochelli, Myriam Boudjoghra, Claude Lesty, Nathalie Cassoux, Christine Fardeau, Thi Ha Chau Tran, Sylvain Choquet, Bishnu Sarker, Caroline Houillier, Agusti Alentorn, Phuc LeHoang, Carole Soussain, Valerie Touitou, Helene Merle-Beral, Khe Hoang-Xuan, Bahram Bodaghi, Kostas Stamatopoulos, Frederic Davi
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1357–1366.
https://doi.org/10.1182/bloodadvances.2019000980
Published: 2020
Includes: Supplemental data